midazolam and sulfobromophthalein

midazolam has been researched along with sulfobromophthalein in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Abe, K; Hirouchi, M; Imaoka, T; Izumi, T; Mikkaichi, T; Okudaira, N	1

Other Studies

2 other study(ies) available for midazolam and sulfobromophthalein

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:7 Topics: Animals; Drug Interactions; Female; Hepatocytes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Metabolic Clearance Rate; Midazolam; Organic Anion Transporters; Rats; Rats, Sprague-Dawley; Rifampin; Sulfobromophthalein	2013

Article

Year

Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.

Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

Topics:

2008

Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor.

Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:7

Topics: Animals; Drug Interactions; Female; Hepatocytes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Metabolic Clearance Rate; Midazolam; Organic Anion Transporters; Rats; Rats, Sprague-Dawley; Rifampin; Sulfobromophthalein

2013